222 related articles for article (PubMed ID: 20978888)
1. Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence.
González-Reyes S; Fernández JM; González LO; Aguirre A; Suárez A; González JM; Escaff S; Vizoso FJ
Cancer Immunol Immunother; 2011 Feb; 60(2):217-26. PubMed ID: 20978888
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of toll-like receptor 3, 4, and 9 in gastric cancer.
Fernandez-Garcia B; Eiró N; González-Reyes S; González L; Aguirre A; González LO; Del Casar JM; García-Muñiz JL; Vizoso FJ
J Immunother; 2014; 37(2):77-83. PubMed ID: 24509170
[TBL] [Abstract][Full Text] [Related]
3. Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis.
González-Reyes S; Marín L; González L; González LO; del Casar JM; Lamelas ML; González-Quintana JM; Vizoso FJ
BMC Cancer; 2010 Dec; 10():665. PubMed ID: 21129170
[TBL] [Abstract][Full Text] [Related]
4. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
Väisänen MR; Väisänen T; Jukkola-Vuorinen A; Vuopala KS; Desmond R; Selander KS; Vaarala MH
Prostate; 2010 Jun; 70(8):817-24. PubMed ID: 20054821
[TBL] [Abstract][Full Text] [Related]
5. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
[TBL] [Abstract][Full Text] [Related]
6. Increased mucosal expression of Toll-like receptor (TLR)2 and TLR4 in coeliac disease.
Szebeni B; Veres G; Dezsofi A; Rusai K; Vannay A; Bokodi G; Vásárhelyi B; Korponay-Szabó IR; Tulassay T; Arató A
J Pediatr Gastroenterol Nutr; 2007 Aug; 45(2):187-93. PubMed ID: 17667714
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis.
Ospelt C; Brentano F; Rengel Y; Stanczyk J; Kolling C; Tak PP; Gay RE; Gay S; Kyburz D
Arthritis Rheum; 2008 Dec; 58(12):3684-92. PubMed ID: 19035519
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma.
Sheyhidin I; Nabi G; Hasim A; Zhang RP; Ainiwaer J; Ma H; Wang H
World J Gastroenterol; 2011 Aug; 17(32):3745-51. PubMed ID: 21990957
[TBL] [Abstract][Full Text] [Related]
9. Expression of Toll-like receptor 4 in the prostate gland and its association with the severity of prostate cancer.
Gatti G; Quintar AA; Andreani V; Nicola JP; Maldonado CA; Masini-Repiso AM; Rivero VE; Maccioni M
Prostate; 2009 Sep; 69(13):1387-97. PubMed ID: 19496069
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of inflammatory response of astrocytes induced by TLR 3 and TLR4 ligation.
Krasowska-Zoladek A; Banaszewska M; Kraszpulski M; Konat GW
J Neurosci Res; 2007 Jan; 85(1):205-12. PubMed ID: 17061254
[TBL] [Abstract][Full Text] [Related]
11. The expression of Toll-like receptors in patients with acute myeloid leukemia treated with induction chemotherapy.
Rybka J; Butrym A; Wróbel T; Jaźwiec B; Stefanko E; Dobrzyńska O; Poręba R; Kuliczkowski K
Leuk Res; 2015 Mar; 39(3):318-22. PubMed ID: 25624047
[TBL] [Abstract][Full Text] [Related]
12. Serine/threonine kinase PKR: a sentinel kinase that discriminates a signaling pathway mediated by TLR4 from those mediated by TLR3 and TLR9.
Asakura Y; Fujiwara Y; Kato N; Sato Y; Komatsu T
Am J Hematol; 2007 Jul; 82(7):640-2. PubMed ID: 17160991
[TBL] [Abstract][Full Text] [Related]
13. IFNs activate toll-like receptor gene expression in viral infections.
Miettinen M; Sareneva T; Julkunen I; Matikainen S
Genes Immun; 2001 Oct; 2(6):349-55. PubMed ID: 11607792
[TBL] [Abstract][Full Text] [Related]
14. Group IIA phospholipase A as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality.
Mirtti T; Laine VJ; Hiekkanen H; Hurme S; Rowe O; Nevalainen TJ; Kallajoki M; Alanen K
APMIS; 2009 Mar; 117(3):151-61. PubMed ID: 19245588
[TBL] [Abstract][Full Text] [Related]
15. Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia.
Kuninaka N; Kurata M; Yamamoto K; Suzuki S; Umeda S; Kirimura S; Arai A; Nakagawa Y; Suzuki K; Kitagawa M
Exp Mol Pathol; 2010 Apr; 88(2):293-8. PubMed ID: 20132814
[TBL] [Abstract][Full Text] [Related]
16. Claudin expression is dysregulated in prostate adenocarcinomas but does not correlate with main clinicopathological parameters.
Coutinho-Camillo CM; Lourenço SV; da Fonseca FP; Soares FA
Pathology; 2011 Feb; 43(2):143-8. PubMed ID: 21233676
[TBL] [Abstract][Full Text] [Related]
17. Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia.
Corthals SL; Wynne K; She K; Shimizu H; Curman D; Garbutt K; Reid GS
Br J Haematol; 2006 Feb; 132(4):452-8. PubMed ID: 16412017
[TBL] [Abstract][Full Text] [Related]
18. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
[TBL] [Abstract][Full Text] [Related]
19. Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma.
Erridge C; Burdess A; Jackson AJ; Murray C; Riggio M; Lappin D; Milligan S; Spickett CM; Webb DJ
Eur J Clin Invest; 2008 Oct; 38(10):713-20. PubMed ID: 18837796
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.
Sukkar MB; Xie S; Khorasani NM; Kon OM; Stanbridge R; Issa R; Chung KF
J Allergy Clin Immunol; 2006 Sep; 118(3):641-8. PubMed ID: 16950283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
